前列腺MRI深度学习模型通过PI-RADS指导的学习有效区分中危病例，在检测csPCa的AUC（0.73-0.88）显著优于放射科医生和临床模型 ...

前列腺MRI靶向活检阴性患者的后续癌症检测率低，临床意义前列腺癌罕见，尤其PI-RADS 3组未检出癌症。基于PI-RADS分类、PSA密度和DRE结果的风险分层管理可减少重复活检需求。 对于PI-RADS 3–5级病变的男性患者，在MRI引导的活检结果为阴性后的最佳随访方案仍存在 ...

Upgrade and downgrade rates from targeted biopsy to radical prostatectomy were not significantly different between patients whose MRI examinations were clinically interpreted using PI-RADS Version ...

Sequential flotufolastat-F18 PSMA-PET scans to enhance detection of prostate cancer in patients with early PSA recurrence following radical prostatectomy. Prevalence of treatment-acquired homozygous ...

AI-assisted imaging improved prostate cancer diagnosis and biopsy decision-making in new research presented at EAU 2026.

But does it cost too much?

The prospective, multi-center phase 3 PRIMARY randomized trial tested the additive diagnostic value of PSMA PET imaging in high-risk men with negative or equivocal MRI in the diagnosis of significant ...

MRI of the prostate, combined with a blood test, can help determine if a prostate lesion is clinically significant cancer, new research suggests An enlarged prostate or potential prostate cancer is a ...

Prostate MRI currently lacks the accuracy to replace biopsies in active surveillance for prostate cancer. The negative predictive value of MRI remains below 90%, the general goal for safely avoiding ...